Synthesis 2024; 56(04): 603-610
DOI: 10.1055/s-0042-1751437
special topic
Synthetic Development of Key Intermediates and Active Pharmaceutical Ingredients (APIs)

Synthesis of Ledipasvir through a Late-Stage Cyclopropanation and Fluorination Process

Chennam Ramu
a   Organic Synthesis & Process Chemistry, CSIR-Indian Institute of Chemical Technology, Tarnaka, Hyderabad-500007, Telangana, India
b   Academy of Scientific and Innovative Research (AcSIR), Ghaziabad-201002, India
,
T. Kumaraguru
a   Organic Synthesis & Process Chemistry, CSIR-Indian Institute of Chemical Technology, Tarnaka, Hyderabad-500007, Telangana, India
b   Academy of Scientific and Innovative Research (AcSIR), Ghaziabad-201002, India
,
M. Sridhar Reddy
a   Organic Synthesis & Process Chemistry, CSIR-Indian Institute of Chemical Technology, Tarnaka, Hyderabad-500007, Telangana, India
b   Academy of Scientific and Innovative Research (AcSIR), Ghaziabad-201002, India
,
Haridas B. Rode
a   Organic Synthesis & Process Chemistry, CSIR-Indian Institute of Chemical Technology, Tarnaka, Hyderabad-500007, Telangana, India
b   Academy of Scientific and Innovative Research (AcSIR), Ghaziabad-201002, India
,
a   Organic Synthesis & Process Chemistry, CSIR-Indian Institute of Chemical Technology, Tarnaka, Hyderabad-500007, Telangana, India
b   Academy of Scientific and Innovative Research (AcSIR), Ghaziabad-201002, India
,
a   Organic Synthesis & Process Chemistry, CSIR-Indian Institute of Chemical Technology, Tarnaka, Hyderabad-500007, Telangana, India
b   Academy of Scientific and Innovative Research (AcSIR), Ghaziabad-201002, India
,
a   Organic Synthesis & Process Chemistry, CSIR-Indian Institute of Chemical Technology, Tarnaka, Hyderabad-500007, Telangana, India
b   Academy of Scientific and Innovative Research (AcSIR), Ghaziabad-201002, India
› Author Affiliations
Financial assistance from Council of Scientific and Industrial Research is gratefully acknowledged [CSIR mission mode project (HCP-0011)].


Abstract

We have designed and developed an easily accessible advanced intermediate of ledipasvir that allowed late-stage cyclopropanation and difluorination, thereby providing a novel and more efficient process for the preparation of ledipasvir in the longest linear sequence of 8 steps with 20% overall yield.

Supporting Information



Publication History

Received: 21 October 2022

Accepted after revision: 27 February 2023

Article published online:
13 April 2023

© 2024. Thieme. All rights reserved

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Lavanchy D. Clin. Microbiol. Infect. 2011; 17: 107
  • 2 https://www.who.int/en/news-room/fact sheets/detail/hepatitis-c (accessed Mar 23, 2023)
    • 4a Guo H, Kato D, Kirschberg TA, Liu H, Link JO, Mitchell ML, Parrish JP, Squires N, Sun J, Taylor J, Bacon EM, Canales E, Cho A, Cottell JJ, Desai MC, Halcomb RL, Krygowski ES, Lazerwith SE, Liu Q, Mackman R, Pyun HJ, Saugier JH, Trenkle JD, Tse WC, Vivian RW, Schroeder SD, Watkins WJ, Xu L, Yang ZY, Kellar T, Sheng X, Clarke MO. N. H, Chou CH, Graupe M, Jin H, McFadden R, Mish MR, Metobo SE, Phillips BW, Venkataramani C. WO 2010132601A1, 2010
    • 4b Scott RW, Vitale JP, Matthews KS, Teresk MG, Formella A, Evans JW. US 20130324740A1, 2013
    • 5a Stella L, Abraham H, Dupont JF, Tinant B, Declercq JP. Tetrahedron Lett. 1990; 31: 2603
    • 5b Scott RW, Vitale JP, Matthews KS, Teresk MG, Formella A, Evans JW. (Gilead Sciences) WO 2013184702, 2013
    • 5c Guo H, Kato D, Kirschberg TA, Liu H, Link JO, Mitchell ML, Parrish JP, Sun J, Taylor J, Bacon EM, Canales E, Cho A, Kim CU, Cottell JJ, Desai MC, Halcomb RL, Lazerwith SE, Mackman RL, Pyun H.-J, Saugier JH, Trenkle JD, Tse WC, Watkins WJ, Xu L. (Gilead Sciences) US 8088368B2, 2012
    • 5d See Scheme 4B for a representative synthetic sequence.
  • 6 Shen Z, Dornan PK, Khan HA, Woo TK, Dong VM. J. Am. Chem. Soc. 2009; 131: 1077
  • 7 Flick AC, Ding HX, Leverett CA, Kyne RE. Jr, Liu KK.-C, Fink SJ, O’Donnell CJ. Bioorg. Med. Chem. 2016; 24: 1937
  • 8 Du X, Zhu G, Chen C. CN 104211677A, 2014
  • 9 A two-step synthetic sequence for fragment I from either direct fluorination on compound 6 or fluorination on compound 2 followed by Friedel–Crafts acylation would have shortened the route, but our efforts in this direction were not successful.
    • 10a Littler BJ, Aizenberg M, Ambhaikar NB, Blythe TA, Curran TT, Dvornikovs V, Jung YC, Jurkauskas V, Lee EC, Looker AR, Luong H, Martinot TA, Miller DB, Neubert-Langille BJ, Otten PA, Rose PJ, Ruggiero PL. Org. Process Res. Dev. 2015; 19: 270
    • 10b Qiu Y.-L, Peng X, Kim IJ, Cao H, Tang D, Or YS, Wang G, Xu G. WO 2012158861A2, 2012
    • 10c Durand X, Hudhomme P, Khan JA, Young DW. J. Chem. Soc., Perkin Trans. 1 1996; 1131
  • 11 Tymtsunik AV, Bilenko VA, Ivon YM, Grygorenko OO, Komarov IV. Tetrahedron Lett. 2012; 53: 3847
  • 12 Gütz C, Bänziger M, Bucher C, Galvão TR, Waldvogel SR. Org. Process Res. Dev. 2015; 19: 1428
  • 14 Kuwano R, Kameyama N, Ikeda R. J. Am. Chem. Soc. 2011; 133: 7312
    • 16a Ji M, Tian X, Zong X, Xu H, Li R, Zhang X. CN 105524049A, 2016
    • 16b Zhang Y, Shen C, Chen S, Hu G, Wei Y, Yu L, Tao X. US 20170253614A1, 2017
    • 16c Lavoie R, James CA, Ruediger EH. WO 2010138488, 2010